KEYTRUDA® (pembrolizumab) KEYNOTE-177 clinical data presentation

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

Click here to download KEYTRUDA KEYNOTE-177 clinical data presentation

PDF, 2.16 MB

KEYNOTE-177 metastatic colorectal cancer (CRC) slide deck providing information on study design, trial endpoints, efficacy and safety.

More information about KEYTRUDA® (pembrolizumab) in metastatic CRC

Visit product page

Supporting documentation

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) 
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website

GB-OVA-00052 | Date of Preparation: August 2022